BOGER JOSHUA S
Insider CIK 1197023 · CRVO Director, 10% owner · VRTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRVO CervoMed Inc. | P Buy deriv | 2026-06-11 | 2026-06-15 | 955,414 | — | $0 | 955,414 | SEC↗ |
| CRVO CervoMed Inc. | P Buy deriv | 2026-06-11 | 2026-06-15 | 955,414 | — | $0 | 955,414 | SEC↗ |
| CRVO CervoMed Inc. | P Buy | 2026-06-11 | 2026-06-15 | 955,414 | $3.14 | $3.00M | 1,795,865 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2026-06-08 | 2026-06-10 | 8,150 | — | $0 | 8,150 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2025-06-23 | 2025-06-25 | 8,100 | — | $0 | 8,100 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2024-06-14 | 2024-06-14 | 5,750 | — | $0 | 5,750 | SEC↗ |
| CRVO CervoMed Inc. | X Exercise deriv | 2024-02-26 | 2024-02-28 | 495,995 | — | $0 | 0 | SEC↗ |
| CRVO CervoMed Inc. | S Sale | 2024-02-26 | 2024-02-28 | 36 | — | $0 | 840,451 | SEC↗ |
| CRVO CervoMed Inc. | X Exercise | 2024-02-26 | 2024-02-28 | 495,995 | — | $0 | 840,487 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2024-02-12 | 2024-02-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-06-08 | 2017-06-09 | 2,941 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-06-08 | 2017-06-09 | 2,941 | — | $0 | 284,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2017-06-01 | 2017-06-05 | 2,941 | — | $0 | 2,941 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2017-06-01 | 2017-06-05 | 5,295 | — | $0 | 5,295 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2017-06-01 | 2017-06-05 | 2,188 | — | $0 | 284,088 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | D To issuer | 2017-06-01 | 2017-06-05 | 2,941 | — | $0 | 281,147 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-01-11 | 2017-01-13 | 8,000 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-01-11 | 2017-01-13 | 1,100 | $84.41 | $92.9K | 268,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-01-11 | 2017-01-13 | 8,000 | $36.30 | $290.4K | 276,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-01-11 | 2017-01-13 | 2,400 | $81.25 | $195.0K | 273,825 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-01-11 | 2017-01-13 | 2,900 | $82.17 | $238.3K | 270,925 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-01-11 | 2017-01-13 | 1,100 | $82.92 | $91.2K | 269,825 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-01-11 | 2017-01-13 | 500 | $84.98 | $42.5K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2017-01-04 | 2017-01-06 | 6,500 | — | $0 | 8,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-01-04 | 2017-01-06 | 1,900 | $77.69 | $147.6K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-01-04 | 2017-01-06 | 4,400 | $76.95 | $338.6K | 270,125 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2017-01-04 | 2017-01-06 | 200 | $75.64 | $15.1K | 274,525 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2017-01-04 | 2017-01-06 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-12-29 | 2017-01-03 | 6,500 | — | $0 | 14,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-12-29 | 2017-01-03 | 5,700 | $74.25 | $423.2K | 269,025 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-12-29 | 2017-01-03 | 800 | $74.86 | $59.9K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-12-29 | 2017-01-03 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-12-21 | 2016-12-22 | 6,500 | — | $0 | 21,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-12-21 | 2016-12-22 | 800 | $75.61 | $60.5K | 268,525 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-12-21 | 2016-12-22 | 4,100 | $73.65 | $302.0K | 270,625 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-12-21 | 2016-12-22 | 1,300 | $74.35 | $96.7K | 269,325 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-12-21 | 2016-12-22 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-12-21 | 2016-12-22 | 300 | $76.39 | $22.9K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-12-14 | 2016-12-16 | 6,500 | — | $0 | 27,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-12-14 | 2016-12-16 | 5,700 | $77.42 | $441.3K | 269,025 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-12-14 | 2016-12-16 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-12-14 | 2016-12-16 | 800 | $78.22 | $62.6K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-12-07 | 2016-12-09 | 6,500 | — | $0 | 34,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-12-07 | 2016-12-09 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-12-07 | 2016-12-09 | 2,600 | $74.63 | $194.0K | 272,125 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-12-07 | 2016-12-09 | 3,800 | $75.48 | $286.8K | 268,325 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-12-07 | 2016-12-09 | 100 | $76.20 | $7.6K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-11-30 | 2016-12-02 | 6,500 | — | $0 | 40,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-30 | 2016-12-02 | 2,100 | $83.48 | $175.3K | 270,425 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-30 | 2016-12-02 | 1,700 | $84.53 | $143.7K | 268,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-30 | 2016-12-02 | 500 | $85.53 | $42.8K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-30 | 2016-12-02 | 2,200 | $82.20 | $180.8K | 272,525 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-11-30 | 2016-12-02 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-11-23 | 2016-11-28 | 6,500 | — | $0 | 47,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-23 | 2016-11-28 | 600 | $85.01 | $51.0K | 274,125 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-11-23 | 2016-11-28 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-23 | 2016-11-28 | 3,900 | $86.43 | $337.1K | 270,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-23 | 2016-11-28 | 2,000 | $86.98 | $174.0K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-11-16 | 2016-11-17 | 6,500 | — | $0 | 53,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-11-16 | 2016-11-17 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-16 | 2016-11-17 | 4,563 | $91.75 | $418.7K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-16 | 2016-11-17 | 1,937 | $91.07 | $176.4K | 272,788 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-11-09 | 2016-11-14 | 6,500 | — | $0 | 60,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-09 | 2016-11-14 | 900 | $93.04 | $83.7K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-11-09 | 2016-11-14 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-09 | 2016-11-14 | 1,400 | $92.10 | $128.9K | 269,125 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-09 | 2016-11-14 | 1,500 | $91.11 | $136.7K | 270,525 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-09 | 2016-11-14 | 1,900 | $90.13 | $171.2K | 272,025 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-09 | 2016-11-14 | 800 | $88.48 | $70.8K | 273,925 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-11-02 | 2016-11-04 | 6,500 | — | $0 | 66,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-02 | 2016-11-04 | 4,000 | $78.05 | $312.2K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-11-02 | 2016-11-04 | 2,500 | $77.28 | $193.2K | 272,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-11-02 | 2016-11-04 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-10-26 | 2016-10-28 | 6,500 | — | $0 | 73,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-26 | 2016-10-28 | 1,600 | $80.74 | $129.2K | 268,325 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-10-26 | 2016-10-28 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-26 | 2016-10-28 | 1,100 | $80.06 | $88.1K | 269,925 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-26 | 2016-10-28 | 1,700 | $78.92 | $134.2K | 271,025 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-26 | 2016-10-28 | 2,000 | $77.80 | $155.6K | 272,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-26 | 2016-10-28 | 100 | $81.85 | $8.2K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-10-19 | 2016-10-21 | 6,500 | — | $0 | 79,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-10-19 | 2016-10-21 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-19 | 2016-10-21 | 6,300 | $81.82 | $515.5K | 268,425 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-19 | 2016-10-21 | 200 | $82.55 | $16.5K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-10-12 | 2016-10-14 | 6,500 | — | $0 | 86,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-10-12 | 2016-10-14 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-12 | 2016-10-14 | 1,400 | $81.28 | $113.8K | 269,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-12 | 2016-10-14 | 1,000 | $82.35 | $82.3K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-12 | 2016-10-14 | 4,100 | $80.79 | $331.2K | 270,625 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-10-05 | 2016-10-07 | 6,500 | — | $0 | 92,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-05 | 2016-10-07 | 800 | $86.68 | $69.3K | 273,925 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-10-05 | 2016-10-07 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-10-05 | 2016-10-07 | 5,700 | $87.55 | $499.0K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-09-28 | 2016-09-30 | 6,500 | — | $0 | 99,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-28 | 2016-09-30 | 600 | $89.11 | $53.5K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-09-28 | 2016-09-30 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-28 | 2016-09-30 | 2,963 | $87.56 | $259.4K | 271,762 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-28 | 2016-09-30 | 2,937 | $88.55 | $260.1K | 268,825 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-09-21 | 2016-09-23 | 6,500 | — | $0 | 105,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-21 | 2016-09-23 | 200 | $92.31 | $18.5K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-09-21 | 2016-09-23 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-21 | 2016-09-23 | 1,900 | $89.73 | $170.5K | 272,825 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-21 | 2016-09-23 | 1,900 | $91.82 | $174.5K | 268,425 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-21 | 2016-09-23 | 2,500 | $90.77 | $226.9K | 270,325 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-09-14 | 2016-09-16 | 6,500 | — | $0 | 112,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-14 | 2016-09-16 | 400 | $88.76 | $35.5K | 274,325 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-14 | 2016-09-16 | 3,500 | $89.80 | $314.3K | 270,825 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-14 | 2016-09-16 | 200 | $90.27 | $18.1K | 270,625 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-14 | 2016-09-16 | 700 | $96.20 | $67.3K | 269,925 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-14 | 2016-09-16 | 1,700 | $97.17 | $165.2K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-09-14 | 2016-09-16 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-09-07 | 2016-09-09 | 6,500 | — | $0 | 118,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-09-07 | 2016-09-09 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-07 | 2016-09-09 | 500 | $96.27 | $48.1K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-09-07 | 2016-09-09 | 6,000 | $95.61 | $573.7K | 268,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-08-31 | 2016-09-02 | 6,500 | — | $0 | 125,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-31 | 2016-09-02 | 800 | $95.28 | $76.2K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-08-31 | 2016-09-02 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-31 | 2016-09-02 | 5,700 | $94.53 | $538.8K | 269,025 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-08-24 | 2016-08-26 | 6,500 | — | $0 | 131,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-08-24 | 2016-08-26 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-24 | 2016-08-26 | 1,100 | $96.73 | $106.4K | 273,625 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-24 | 2016-08-26 | 100 | $99.50 | $9.9K | 272,525 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-24 | 2016-08-26 | 1,500 | $101.21 | $151.8K | 271,025 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-24 | 2016-08-26 | 2,800 | $101.83 | $285.1K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-24 | 2016-08-26 | 100 | $100.02 | $10.0K | 79,100 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-24 | 2016-08-26 | 900 | $101.60 | $91.4K | 78,200 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-24 | 2016-08-26 | 1,000 | $98.74 | $98.7K | 272,625 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-22 | 2016-08-24 | 100 | $101.39 | $10.1K | 79,200 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-22 | 2016-08-24 | 1,000 | $100.73 | $100.7K | 79,300 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-08-17 | 2016-08-18 | 6,500 | — | $0 | 138,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-17 | 2016-08-18 | 4,000 | $99.36 | $397.4K | 270,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-17 | 2016-08-18 | 2,500 | $99.99 | $250.0K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-17 | 2016-08-18 | 400 | $100.03 | $40.0K | 80,300 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-08-17 | 2016-08-18 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-11 | 2016-08-12 | 900 | $100.19 | $90.2K | 80,700 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-08-10 | 2016-08-11 | 6,500 | — | $0 | 144,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-10 | 2016-08-11 | 1,600 | $100.93 | $161.5K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-10 | 2016-08-11 | 400 | $100.38 | $40.2K | 81,800 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-10 | 2016-08-11 | 200 | $101.34 | $20.3K | 81,600 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-10 | 2016-08-11 | 4,900 | $99.96 | $489.8K | 269,825 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-08-10 | 2016-08-11 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-08-03 | 2016-08-05 | 6,500 | — | $0 | 151,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-08-03 | 2016-08-05 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-03 | 2016-08-05 | 3,300 | $100.09 | $330.3K | 271,425 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-03 | 2016-08-05 | 3,200 | $100.74 | $322.4K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-03 | 2016-08-05 | 10,000 | $101.17 | $1.01M | 82,200 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-08-03 | 2016-08-05 | 30,500 | $100.55 | $3.07M | 92,200 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-07-27 | 2016-07-29 | 6,500 | — | $0 | 157,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-27 | 2016-07-29 | 6,100 | $95.89 | $584.9K | 268,625 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-27 | 2016-07-29 | 400 | $96.55 | $38.6K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-07-27 | 2016-07-29 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-07-20 | 2016-07-22 | 6,500 | — | $0 | 164,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-07-20 | 2016-07-22 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-20 | 2016-07-22 | 300 | $87.69 | $26.3K | 274,425 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-20 | 2016-07-22 | 600 | $88.92 | $53.4K | 273,825 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-20 | 2016-07-22 | 3,000 | $90.91 | $272.7K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-20 | 2016-07-22 | 2,600 | $90.28 | $234.7K | 271,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-07-13 | 2016-07-15 | 6,500 | — | $0 | 170,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-13 | 2016-07-15 | 1,800 | $89.68 | $161.4K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-07-13 | 2016-07-15 | 6,500 | $36.30 | $235.9K | 274,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-13 | 2016-07-15 | 4,700 | $88.47 | $415.8K | 270,025 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-07-06 | 2016-07-08 | 5,140 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-07-06 | 2016-07-08 | 5,140 | $35.35 | $181.7K | 273,365 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-06 | 2016-07-08 | 100 | $86.47 | $8.6K | 273,265 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-06 | 2016-07-08 | 600 | $87.99 | $52.8K | 272,665 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-06 | 2016-07-08 | 140 | $89.69 | $12.6K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-07-06 | 2016-07-08 | 4,300 | $89.17 | $383.4K | 268,365 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-06-29 | 2016-06-30 | 5,130 | — | $0 | 5,140 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-06-29 | 2016-06-30 | 5,130 | $35.35 | $181.3K | 273,355 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-29 | 2016-06-30 | 3,030 | $85.29 | $258.4K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-29 | 2016-06-30 | 1,100 | $84.68 | $93.1K | 271,255 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-29 | 2016-06-30 | 1,000 | $83.53 | $83.5K | 272,355 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-06-22 | 2016-06-24 | 5,130 | — | $0 | 10,270 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-22 | 2016-06-24 | 2,430 | $85.84 | $208.6K | 270,925 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-22 | 2016-06-24 | 1,500 | $86.54 | $129.8K | 269,425 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-22 | 2016-06-24 | 500 | $87.81 | $43.9K | 268,925 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-06-22 | 2016-06-24 | 5,130 | $35.35 | $181.3K | 273,355 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-22 | 2016-06-24 | 700 | $88.58 | $62.0K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-06-15 | 2016-06-17 | 5,130 | — | $0 | 15,400 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-15 | 2016-06-17 | 5,130 | $91.18 | $467.8K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-06-15 | 2016-06-17 | 5,130 | $35.35 | $181.3K | 273,355 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-06-08 | 2016-06-10 | 5,130 | — | $0 | 25,660 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-08 | 2016-06-10 | 4,930 | $94.93 | $468.0K | 268,425 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-06-08 | 2016-06-10 | 5,130 | $35.35 | $181.3K | 273,355 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-08 | 2016-06-10 | 200 | $95.57 | $19.1K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-06-01 | 2016-06-03 | 5,130 | — | $0 | 30,790 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2016-06-01 | 2016-06-03 | 7,073 | — | $0 | 7,073 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-01 | 2016-06-03 | 200 | $94.04 | $18.8K | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-06-01 | 2016-06-03 | 4,930 | $93.63 | $461.6K | 268,425 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-06-01 | 2016-06-03 | 5,130 | $35.35 | $181.3K | 273,355 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2016-06-01 | 2016-06-03 | 2,941 | $0.01 | $29 | 268,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-05-25 | 2016-05-27 | 5,130 | — | $0 | 30,790 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-25 | 2016-05-27 | 4,500 | $89.02 | $400.6K | 265,914 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-05-25 | 2016-05-27 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-25 | 2016-05-27 | 630 | $89.57 | $56.4K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-05-18 | 2016-05-20 | 5,130 | — | $0 | 35,920 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-05-18 | 2016-05-20 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-18 | 2016-05-20 | 4,430 | $81.08 | $359.2K | 265,984 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-18 | 2016-05-20 | 700 | $81.84 | $57.3K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-05-11 | 2016-05-13 | 5,130 | — | $0 | 41,050 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-05-11 | 2016-05-13 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-11 | 2016-05-13 | 430 | $83.90 | $36.1K | 269,984 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-11 | 2016-05-13 | 1,200 | $85.26 | $102.3K | 268,784 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-11 | 2016-05-13 | 1,600 | $86.78 | $138.8K | 267,184 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-11 | 2016-05-13 | 1,400 | $87.43 | $122.4K | 265,784 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-11 | 2016-05-13 | 500 | $88.20 | $44.1K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-05-04 | 2016-05-06 | 5,130 | — | $0 | 46,180 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-05-04 | 2016-05-06 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-04 | 2016-05-06 | 700 | $81.79 | $57.3K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-05-04 | 2016-05-06 | 4,430 | $80.90 | $358.4K | 265,984 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-04-27 | 2016-04-29 | 5,130 | — | $0 | 51,310 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-04-27 | 2016-04-29 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-27 | 2016-04-29 | 1,800 | $83.53 | $150.4K | 267,214 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-27 | 2016-04-29 | 400 | $85.45 | $34.2K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-27 | 2016-04-29 | 1,530 | $84.57 | $129.4K | 265,684 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-27 | 2016-04-29 | 1,400 | $82.35 | $115.3K | 269,014 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-04-20 | 2016-04-22 | 5,130 | — | $0 | 56,440 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-04-20 | 2016-04-22 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-20 | 2016-04-22 | 4,830 | $84.06 | $406.0K | 265,584 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-20 | 2016-04-22 | 300 | $84.69 | $25.4K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-04-13 | 2016-04-15 | 5,130 | — | $0 | 61,570 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-13 | 2016-04-15 | 1,830 | $85.09 | $155.7K | 265,384 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-04-13 | 2016-04-15 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-13 | 2016-04-15 | 3,200 | $83.76 | $268.0K | 267,214 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-13 | 2016-04-15 | 100 | $85.50 | $8.6K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-04-06 | 2016-04-08 | 5,130 | — | $0 | 66,700 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-04-06 | 2016-04-08 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-06 | 2016-04-08 | 800 | $89.53 | $71.6K | 268,214 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-06 | 2016-04-08 | 500 | $88.19 | $44.1K | 269,014 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-06 | 2016-04-08 | 900 | $86.56 | $77.9K | 269,514 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-06 | 2016-04-08 | 2,230 | $90.60 | $202.0K | 265,984 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-04-06 | 2016-04-08 | 700 | $91.12 | $63.8K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-03-30 | 2016-04-01 | 5,130 | — | $0 | 71,830 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-30 | 2016-04-01 | 820 | $78.90 | $64.7K | 266,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-30 | 2016-04-01 | 3,310 | $78.31 | $259.2K | 267,104 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-30 | 2016-04-01 | 400 | $81.07 | $32.4K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-30 | 2016-04-01 | 600 | $80.08 | $48.0K | 265,684 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-03-30 | 2016-04-01 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-03-23 | 2016-03-25 | 5,130 | — | $0 | 76,960 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-23 | 2016-03-25 | 900 | $81.48 | $73.3K | 266,484 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-23 | 2016-03-25 | 3,030 | $80.64 | $244.3K | 267,384 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-23 | 2016-03-25 | 200 | $84.54 | $16.9K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-03-23 | 2016-03-25 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-23 | 2016-03-25 | 800 | $82.77 | $66.2K | 265,684 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-23 | 2016-03-25 | 200 | $83.33 | $16.7K | 265,484 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-03-16 | 2016-03-18 | 5,130 | — | $0 | 82,090 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-16 | 2016-03-18 | 300 | $81.00 | $24.3K | 266,084 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-16 | 2016-03-18 | 600 | $82.27 | $49.4K | 265,484 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-16 | 2016-03-18 | 200 | $82.98 | $16.6K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-16 | 2016-03-18 | 1,197 | $79.98 | $95.7K | 266,384 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-03-16 | 2016-03-18 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-16 | 2016-03-18 | 1,300 | $78.07 | $101.5K | 269,114 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-16 | 2016-03-18 | 1,533 | $79.00 | $121.1K | 267,581 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-03-09 | 2016-03-11 | 5,130 | — | $0 | 87,220 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-09 | 2016-03-11 | 2,300 | $85.84 | $197.4K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-03-09 | 2016-03-11 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-09 | 2016-03-11 | 2,830 | $84.94 | $240.4K | 267,584 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-03-02 | 2016-03-04 | 5,130 | — | $0 | 92,350 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-02 | 2016-03-04 | 530 | $92.50 | $49.0K | 269,295 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-03-02 | 2016-03-04 | 5,130 | $35.35 | $181.3K | 274,425 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-02 | 2016-03-04 | 700 | $91.19 | $63.8K | 273,725 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-03-02 | 2016-03-04 | 3,900 | $91.82 | $358.1K | 269,825 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-02-24 | 2016-02-26 | 5,130 | — | $0 | 97,480 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-24 | 2016-02-26 | 1,400 | $84.03 | $117.6K | 272,825 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-02-24 | 2016-02-26 | 5,130 | $35.35 | $181.3K | 274,425 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-24 | 2016-02-26 | 1,700 | $85.20 | $144.8K | 271,125 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-24 | 2016-02-26 | 1,830 | $86.50 | $158.3K | 269,295 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-24 | 2016-02-26 | 200 | $82.90 | $16.6K | 274,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-02-17 | 2016-02-19 | 5,130 | — | $0 | 102,610 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-17 | 2016-02-19 | 1,830 | $87.53 | $160.2K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-17 | 2016-02-19 | 3,000 | $86.74 | $260.2K | 267,114 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-17 | 2016-02-19 | 300 | $85.16 | $25.5K | 270,114 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-02-17 | 2016-02-19 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-02-10 | 2016-02-12 | 5,130 | — | $0 | 107,740 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-10 | 2016-02-12 | 1,400 | $83.34 | $116.7K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-02-10 | 2016-02-12 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-10 | 2016-02-12 | 1,330 | $81.65 | $108.6K | 269,084 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-10 | 2016-02-12 | 2,400 | $82.64 | $198.3K | 266,684 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-02-03 | 2016-02-05 | 5,130 | — | $0 | 112,870 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-03 | 2016-02-05 | 500 | $88.11 | $44.1K | 269,714 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-03 | 2016-02-05 | 1,100 | $89.60 | $98.6K | 268,614 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-03 | 2016-02-05 | 1,300 | $90.63 | $117.8K | 267,314 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-03 | 2016-02-05 | 200 | $86.66 | $17.3K | 270,214 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-03 | 2016-02-05 | 700 | $91.58 | $64.1K | 266,614 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-03 | 2016-02-05 | 800 | $92.94 | $74.4K | 265,814 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-02-03 | 2016-02-05 | 530 | $93.61 | $49.6K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-02-03 | 2016-02-05 | 5,130 | $35.35 | $181.3K | 270,414 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-01-27 | 2016-01-29 | 11,200 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-01-27 | 2016-01-29 | 2,400 | $93.00 | $223.2K | 270,084 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2016-01-27 | 2016-01-29 | 11,200 | $35.64 | $399.2K | 276,484 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-01-27 | 2016-01-29 | 700 | $90.70 | $63.5K | 275,784 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-01-27 | 2016-01-29 | 100 | $95.71 | $9.6K | 265,284 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-01-27 | 2016-01-29 | 2,100 | $94.94 | $199.4K | 265,384 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-01-27 | 2016-01-29 | 2,600 | $94.10 | $244.7K | 267,484 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-01-27 | 2016-01-29 | 3,300 | $92.04 | $303.7K | 272,484 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2016-01-20 | 2016-01-22 | 10,400 | — | $0 | 11,200 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-01-20 | 2016-01-22 | 800 | $96.18 | $76.9K | 266,384 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-01-20 | 2016-01-22 | 1,900 | $95.24 | $181.0K | 267,184 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2016-01-20 | 2016-01-22 | 1,300 | $93.71 | $121.8K | 269,084 | SEC↗ |